Avedro Announces CE Mark for its Newest Riboflavin Formulations – StreetInsider.com

WALTHAM, Mass.–(BUSINESS WIRE)– Avedro, Inc., a global ophthalmic medical device and pharmaceutical company, has announced that it has expanded its portfolio of proprietary riboflavin formulations for corneal collagen cross-linking. When used in …